Currax Pharmaceuticals LLC
At a glance
Employees100-499
In business sinceNot reported
HeadquartersBrentwood, TN
US patents13
SAM.gov UEIEML3QN8RU5N7
CAGE code8HRJ9
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
13 US patents granted 2019–2025, 7 of them in the five years to SEP 2025.
Pharmaceuticals 13
- Pharmaceutical formulations comprising naltrexone and/or bupropionUS 12,303,604 · granted MAY 20, 2025
- Methods of using low-dose doxepin for the improvement of sleepUS 12,083,090 · granted SEP 10, 2024
- Low-dose doxepin for treatment of sleep disorders in elderly patientsUS 11,234,954 · granted FEB 1, 2022
- Methods of improving the pharmacokinetics of doxepinUS 11,110,074 · granted SEP 7, 2021
- Low-dose doxepin formulations and methods of making and using the sameUS 11,096,920 · granted AUG 24, 2021
Newest 5 shown · Granted to Currax Pharmaceuticals LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Currax Pharmaceuticals LLC | Brentwood | TN | 100–499 | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.